Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study

Table 1 Standard treatments with curettage for GCTB^a in 24 institutions

Treatments	No. of institutions (%)
Local adjuvants
High-speed burr	22 (92%)
Ethanol	8 (33%)
Liquid nitrogen	6 (25%)
Phenol	3 (13%)
Reconstruction after curettage
Autologous bone graft	18 (75%)
PMMA^b	17 (71%)
β-TCP^c	11 (46%)
Hydroxyapatite	10 (42%)
Allogeneic bone graft	2 (8%)

^aGCTB giant cell tumor of bone
^bPMMA, polymethyl methacrylate
^cβ-TCP, β tricalcium phosphate; some of the replies by responded institutions are overlapped

ISSN: 1477-7819